Physician

Ethan Brandon Rutledge, D.O.

According to 2025 Medicare claims, Ethan Rutledge, D.O. (NPI: 1508156696) practices pulmonary disease in the Cleveland, TN market, with the plurality of this provider's patient population coming from Bradley, TN. This provider's primary affiliated billing organization is BLUE RIDGE PULMONARY MEDICINE, PC (NPI: 1487601019; TIN: 62-1482378) and primary practice location at 37311-3883.

Rutledge's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 637 traditional Medicare patients, billed 2,972 HCPCS/CPT codes, and received $169,697 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,304 prescription claims across 671 beneficiaries totaling $1,908,380 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,874 claims. Open Payments data shows 122 records totaling $2,722. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $19,362 to $169,697. Similarly, Part D prescription costs have moved sharply higher in recent years, from $16,831 to $1,908,380. For DME billing, reported payments rose steadily, from $13,239 to $130,900.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	132	145	$19,362
2016	116	118	$16,504
2017	294	1,045	$78,484
2018	591	2,981	$197,782
2019	546	2,928	$189,173
2020	548	3,019	$188,258
2021	556	2,876	$199,316
2022	533	2,765	$190,080
2023	548	2,685	$167,544
2024	637	2,972	$169,697

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	54	157	$16,831
2016	32	138	$30,784
2017	76	216	$47,896
2018	207	816	$252,223
2019	314	1,647	$609,762
2020	401	2,500	$1,090,035
2021	448	2,860	$1,673,396
2022	494	3,084	$2,016,671
2023	544	3,796	$2,105,537
2024	671	4,304	$1,908,380

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	65	89	$2,844
2018	461	1,291	$62,527
2019	741	2,426	$95,560
2020	906	3,044	$153,210
2021	886	3,205	$192,667
2022	819	2,907	$178,549
2023	868	2,868	$173,375
2024	917	2,874	$146,476

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	304	463	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	248	329	$60
71046	X-ray of chest, 2 views	227	267	$23
94010	Test to measure expiratory airflow and volume	281	333	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	207	315	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	901	34,380	$726,172
Uptravi	Selexipag	12	360	$281,389
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	261	8,940	$183,697
Opsumit	Macitentan	13	390	$167,960
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	199	7,050	$107,262

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	58	390	$29,950
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	23	$17,571
A7031	Face mask interface, replacement for full face mask, each	N	69	192	$16,519
A7030	Full face mask used with positive airway pressure device, each	N	70	172	$14,867
E0601	Continuous positive airway pressure (cpap) device	Y	46	243	$8,642

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	122	$2,722	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ethan Brandon Rutledge, D.O.?

Tedicare shows public-source Medicare data for Ethan Brandon Rutledge, D.O. (NPI 1508156696), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ethan Brandon Rutledge, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ethan Brandon Rutledge, D.O.?

Ethan Brandon Rutledge, D.O. is linked to BLUE RIDGE PULMONARY MEDICINE, PC (billing NPI 1487601019) in the available physician profile data.

Does Ethan Brandon Rutledge, D.O. have Open Payments data?

Ethan Brandon Rutledge, D.O. has 122 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.